Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Start-Up to Tackle Neurodegenerative Diseases, Raises $31 Million

Magnolia Neuroscience

A new company is forming to develop treatments that protect against destruction of brain cells in Alzheimer’s disease and comparable nerve damage from chemotherapy. . . . → Read More: Start-Up to Tackle Neurodegenerative Diseases, Raises $31 Million

Graphene Tested in Space Launch

Graphene samples

The material graphene, studied for more than a decade on earth, is the subject of tests for its ability to withstand the rigors of space travel. . . . → Read More: Graphene Tested in Space Launch

Allergan Licensing Crispr for Inherited Eye Disease

Editing DNA

Drug maker Allergan is acquiring the rights from Editas Medicine to develop an application of the genome-editing technology Crispr for the inherited eye disease Leber congenital amaurosis type 10. . . . → Read More: Allergan Licensing Crispr for Inherited Eye Disease

Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal

T-cells illustration

Two biotechnology companies with complementary technologies plan to create treatments for cancer that harness and modify cells from the immune system delivered with benign viruses. . . . → Read More: Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal

Engineered Bacteria Studied for Rare Inherited Skin Disorder

f Staphylococcus epidermidis

A biotechnology company and research lab are evaluating a modified skin bacteria as a treatment for Netherton syndrome, a rare inherited skin disease affecting mainly infants and young children. . . . → Read More: Engineered Bacteria Studied for Rare Inherited Skin Disorder

Technique Assessed for Comparing Effectiveness Between Drugs

Analytics

An academic-industry research team validated a statistical technique to evaluate the effectiveness of different drugs treating the same disease, without conducting separate head-to-head clinical trials. . . . → Read More: Technique Assessed for Comparing Effectiveness Between Drugs

BASF, UC-Davis Partner on Human Milk Sugars

Breastfeeding mother

BASF and a research institute at University of California in Davis are investigating complex sugars found in human breast milk, and their role in maintaining healthy gut microbes. . . . → Read More: BASF, UC-Davis Partner on Human Milk Sugars

GSK, 23andMe Ink Precision Meds Discovery Deal

Saliva sample kit

Consumer genetics company 23andMe signed a 4-year agreement to help drug maker GlaxoSmithKline find more precise drug targets and recruit clinical trial participants likely to respond to treatments. . . . → Read More: GSK, 23andMe Ink Precision Meds Discovery Deal

NSF, Industry Group Fund Bio-Based Semiconductor R&D

Biocircuits illustration

A research consortium in the semiconductor industry and National Science Foundation are supporting a series of projects investigating interactions between biology and circuits for data transfer and storage. . . . → Read More: NSF, Industry Group Fund Bio-Based Semiconductor R&D

Big Data, A.I. Applied to Precision Medicine for Lung Disease

Human lungs illustration

A medical analytics company and two academic scientists are applying artificial intelligence technologies to discover precise therapies for people with idiopathic pulmonary fibrosis, a chronic lung disease. . . . → Read More: Big Data, A.I. Applied to Precision Medicine for Lung Disease